Global Blood Therapeutics Inc. (GBT)

53.98
NASDAQ : Health Technology
Prev Close 57.52
Day Low/High 51.30 / 57.74
52 Wk Low/High 30.15 / 63.00
Avg Volume 663.50K
Exchange NASDAQ
Shares Outstanding 56.41M
Market Cap 3.24B
EPS -3.40
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Strength in Growth Names Is Giving the Market a More Upbeat Feel

Strength in Growth Names Is Giving the Market a More Upbeat Feel

Apple in particular is helping the bullish cause.

Heineken Stock Boosted By China Deal as Jefferies Downgrades

Heineken Stock Boosted By China Deal as Jefferies Downgrades

If there is any good news on trade the potential for more market upside is strong.

Play the Hemorrhage in Global Blood's Stock

Play the Hemorrhage in Global Blood's Stock

I see the $32.50 to $35 area as major support for GBT.

These Biotechs Are Movers Today

The market is down across the board as one might expect given escalating trade tensions today. However, losses are slight in this context in the first hour of trading. Given the option expiration date, volatility could pick up later in the day. Some...

Even Momentum Traders Should Study Stock Charts

Even Momentum Traders Should Study Stock Charts

You don't have to 'believe' in technical analysis to use it to set your exit and entry points.

Many Names on My Radar

Many Names on My Radar

There is no question that we are becoming extended and ripe for some profit taking.

Having Some Good Luck With Biotech Names

Having Some Good Luck With Biotech Names

Overall it is still a positive day but the action is sloppy.

Markets Make an Art of Unpredictability

Markets Make an Art of Unpredictability

Oil isn't the only reason stocks are higher.

Markets Confused by Trump's Upcoming Iran Decision

Markets Confused by Trump's Upcoming Iran Decision

No matter what happens with Iran, it is not going to be a major market positive.

5 Stocks That Are Showing Signs of Reversing

5 Stocks That Are Showing Signs of Reversing

These names are showing technical characteristics of either bullish or bearish reversal patterns over the past week.

With an Eye on Biotech, Here's Today's Trading Thesis

With an Eye on Biotech, Here's Today's Trading Thesis

It is important to note that watching for a reversal is much different than being short.

The Confidence in the Dip Buyers Has Weakened

The Confidence in the Dip Buyers Has Weakened

The bears are likely to be increasingly bold if there's a failed bounce.

This Market Badly Needs a Rest

This Market Badly Needs a Rest

It would be a longer-term positive if the overbought conditions are alleviated.

The Stock Market Is Facing One Big Obstacle Right Now

The Stock Market Is Facing One Big Obstacle Right Now

You have to wonder how much longer we can run without a pullback of at least 2%.

Markets Nicely Off Today's Lows

Markets are down across the board in the first hour of trading. However, we are nicely off the lows of the day. Financials are bucking the early downward tilt of the market and are up today. This sector continues to benefit from slowly rising intere...

Selling Action Is Upon Us

Selling Action Is Upon Us

There is still a very strong appetite for individual stocks with momentum.

Focused on Stock Picking Through This Volatility

Focused on Stock Picking Through This Volatility

I'm trying not to be sucked into the market-timing game and am looking mainly at setups in individual stocks.

The Return of Stock Market Volatility Can Create Stellar Opportunities

The Return of Stock Market Volatility Can Create Stellar Opportunities

But you need to be selective and have discipline.

Markets Get Back to Business as Usual

Markets Get Back to Business as Usual

U.S. stocks move higher after early slip, as investors digest Apple's latest results.

DBV Shares Fall After Phase 3 Data on Peanut Allergy Treatment -- Biotech Movers

DBV Shares Fall After Phase 3 Data on Peanut Allergy Treatment -- Biotech Movers

The Montrouge, France-based firm on Friday unveiled top-line results from its Phase 3 study of a peanut allergy treatment. The study, dubbed Pepites, evaluated Viaskin Peanut in children four to 11 years old.

Global Blood Therapeutics Makes a Bold Move

Global Blood Therapeutics Makes a Bold Move

This stock's old highs may come into play.

Biotech Names Flexing Their Muscles

Biotech Names Flexing Their Muscles

There's action in Global Blood Therapeutics and Antares Pharma.

Hoping for Negative Seasonality, but Market's Not Holding Its Breadth

Hoping for Negative Seasonality, but Market's Not Holding Its Breadth

The major indices barely budged intraday this week, as we had the narrowest trading range ever.

Russell Rebalancing Tops Off a Choppy Week

Russell Rebalancing Tops Off a Choppy Week

It's hard to be too negative considering the speculative action today.

There's No Rush for the Exits So Far

There's No Rush for the Exits So Far

There's lots of negativity, but dip buyers are showing up.

Market Is Home on the Range Again

Market Is Home on the Range Again

Emotion of yesterday's collapse is pretty much gone.

Traders Are Aggressively Fading the Open

Traders Are Aggressively Fading the Open

But what will be most important is whether support stays strong and the buyers show interest in the afternoon.